Cannula Market Size - By Product (Cardiac, Nasal, Dermatology), By Type (Neonatal, Straight, Winged), By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), By Material (Plastic, Metal, Silicone), By End-use – Global Forecast to 2032

Cannula Market Size - By Product (Cardiac, Nasal, Dermatology), By Type (Neonatal, Straight, Winged), By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), By Material (Plastic, Metal, Silicone), By End-use – Global Forecast to 2032

Cannula Market Size

Cannula Market size was valued at USD 162.1 million in 2022 and is projected to reach USD 335 million by 2032. Cannulas are commonly used in medical procedures to deliver or remove fluids, gases, or medications to or from different parts of the body. They are often used in intravenous (IV) equipment to administer fluids, medications, or blood products directly into a vein. Cannulas can also be used for drainage, such as removing excess fluids or gases from body cavities or organs.
 

Additionally, the rising incidence of infections, growing number of geriatric population base, immunocompromised patients, and chronic illness patients. For instance, according to the World Health Organization (WHO), infection affects an estimated 49 million individuals and causes 11 million deaths globally, every year. Further, around half (49%) of patients with sepsis in intensive care units acquire infection in the hospital, annually.
 

Furthermore, rising geriatric population base is significantly impacting the expansion of the industry. For instance, 30% of the population base in Japan is already over 60 years of age. In addition, a sedentary lifestyle, lack of physical activities, and unhygienic conditions will further increase the disease burden among geriatric people. Thus, the growing disease burden will upsurge the demand for surgical and non-surgical procedures which increases the requirement for cannulas in healthcare settings.
 

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the cannula market. The COVID-19 pandemic led to a surge in hospitalizations and the need for respiratory support. This resulted in a higher demand for cannulas used for oxygen delivery and respiratory therapies, such as nasal cannulas and high-flow nasal cannulas. Additionally, infection prevention and control measures became paramount during the pandemic. Healthcare facilities increased their efforts to prevent the spread of infections, including through the use of sterile and single-use medical devices such as cannulas. This increased emphasis on infection control and influenced the demand for specific types of cannulas.
 

Cannula Market Trends

The growing burden of chronic disease is anticipated to stimulate market value. Chronic diseases often require long-term management and treatment, which may involve the use of medical devices including cannulas. Conditions such as diabetes, cardiovascular diseases, respiratory disorders, and certain types of cancer may require regular administration of medications, fluids, or other therapies using cannulas. For instance, in 2022, as per estimates, about 80% of the elderly population base have at least one chronic condition, and approximately 60% have around two chronic conditions. Furthermore, increasing number of infections led to higher adoption rate of infection control supplies including cannula.
 

Cannula Market Analysis

Based on product, the cannula market is segmented into cardiac, nasal, dermatology, and others. The cardiac segment is further subdivided into venous, arterial, and cardioplegia. The cardiac segment witnessed the largest revenue size at USD 73.2 million in 2022 and is estimated to witness USD 152.8 million by 2032. Cardiac cannulas provide access to the heart chambers and major blood vessels, allowing for various interventions. They can be inserted into the aorta, superior vena cava, inferior vena cava, and other cardiac structures, enabling delivery or removal of blood, medications, and fluids.

Moreover, some cardiac cannulas are equipped with temperature control features, such as heat exchangers or warmers. These devices allow for precise control of the patient's body temperature during cardiac surgery, which is crucial for maintaining optimal conditions and reducing the risk of complications. Furthermore, an increasing availability of cardiovascular devices along with various other businesses working towards creating novel technology.
 

Cannula market is bifurcated based on the type into neonatal, straight, winged, and others. The straight segment is anticipated to reach at USD 127.9 million by 2032. Straight cannulas are commonly used in conjunction with infusion sets or IV administration sets. These sets include additional components such as tubing, connectors, and control devices, and the straight cannula serves as the entry point for medication or fluid delivery. The compatibility with standard infusion sets makes straight cannulas widely used in healthcare settings.
 

In addition, straight cannulas are generally more cost-effective compared to more specialized or advanced cannulas. They are widely available and come at lower price points, making them suitable for routine medical procedures and healthcare facilities with budget constraints. Therefore, owing to the aforementioned factors straight cannulas are widely used. However, neonatal cannulas are anticipated to grow at highest CAGR at 7.9% by 2032. Increasing awareness regarding neonatal infant care and rising novel product launches.
 

The cannula market is segmented by size into 14G, 16G, 18G, 20G, 22G, 24G, and 26G. The 18G segment dominated the industry accounting for more than 25% market share in 2022 and is estimated to witness USD 88.5 million by 2032. 18G cannulas are considered versatile because they can accommodate a variety of medical procedures and applications. They are commonly used for intravenous (IV) therapy, blood transfusions, and other procedures that require the administration of fluids, medications, or blood products.
 

The 18G size provides an appropriate balance between flow rate and patient comfort for many routine medical interventions. Moreover, the 18G cannulas are widely available in medical settings and are a standard option in many healthcare facilities. Their widespread use has made them familiar to healthcare professionals, which contributes to ease of use and efficient insertion.
 

The cannula market is segmented by material into plastic, metal, and silicone. The plastic segment is estimated to witness significant revenue at USD 190.1 million by 2032. Plastic cannulas are typically made of flexible materials such as polyurethane or polyethylene. This flexibility allows them to bend and conform to the body's contours, making them more comfortable for patients. The softness of plastic cannulas reduces the risk of tissue damage or irritation during insertion and use. Plastic cannulas are typically lighter in weight compared to metal cannulas. This can improve patient comfort, particularly during longer-term use or when multiple cannulas are needed. Additionally, plastic cannulas are generally more cost-effective, making them a preferred choice in healthcare settings with budget constraints.
 

The cannula market is segmented by end-use into hospitals, ambulatory surgical centers, specialty centers, and others. Hospitals segment dominated the industry accounting for more than 49% market share in 2022 and is estimated to witness USD 167.9 million by 2032. Cannulas play a crucial role in emergency and critical care settings, where prompt and reliable access to the patient's circulatory system is essential. They enable the rapid administration of life-saving medications, fluids, or blood products in emergency situations or during resuscitation efforts, will result in hospitals dominating the cannula industry. Furthermore, improved research and diagnosis in hospital laboratories, as well as increased disposable income in developed nations, will significantly contribute to the use of cannula in hospitals.
 

U.S. cannula market accounted for USD 61.3 million in 2022 and will grow momentously to reach USD 124.5 million by 2032. The affordability of medical procedures among the target population base and ongoing technological developments are primarily responsible for the development of the industry value. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America industry. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.
 

Cannula Market Share

Some of the notable key industry players operating in the cannula market include

• Medtronic
•  Becton Dickinson (BD)
•  Edward Lifesciences
•  LivaNova
•  Smiths Medical
•  Boston Scientific Corporation
•  Terumo Corporation
•  Fisher & Paykel Healthcare Ltd
•  Flexicare Medical
•  Medin Medical Innovations
•  Salter Labs
•  Vapotherm

Cannula Industry News

• In January 2023, Sterimedix displayed the development of ophthalmic and aesthetic cannulas at Arab Health as a part of its ongoing worldwide market expansion. Such initiative offers competitive edge to the firm in the significant market.
   

Cannula market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product (USD Million)

• Nasal  
• Dermatology 
• Cardiac
• Arterial
• Venous
• Cardioplegia

• Others

By Type (USD Million)

• Neonatal
• Straight
• Winged
• Others

By Size (USD Million)

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G   

By Material (USD Million)

• Plastic
• Metal
• Silicone

By End-use (USD Million)

• Hospitals
• Ambulatory surgical centers
• Specialty centers
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Norway
  • Finland
  • Sweden
  • Denmark
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Taiwan
  • Indonesia
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel